Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sugen and Asta Medica make progress in Pan-HER collaboration

Jan. 16, 1998

SU-101 advances to phase III for relapsed glioblastoma

Jan. 16, 1998

Gliadel Wafer enters additional phase III study

Jan. 16, 1998

Onyx and Warner-Lambert renew cell cycle regulation agreement

Jan. 16, 1998

Cancer gene therapy technology available for licensing from NIH

Jan. 16, 1998

Novel tumor vaccine technology described by U.S. researchers

Jan. 15, 1998

Pacific receives patent allowance for immune system stimulant

Jan. 15, 1998

New proto-oncogene inhibitor isolated from fungus by Schering-Plough

Jan. 15, 1998

Pharma Mar discovers new antitumor heptapeptide from Australian ascidian

Jan. 15, 1998

Indian researchers describe new anticancer agent

Jan. 14, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...